Department of Intensive Care Medicine, Radboud university medical center
Nijmegen, 6500HB, Netherlands
Location status: Recruiting
NCT Number: NCT04523909
Observational prospective pilot study to analyze the trajectory of neuroinflammatory protein expression in cerebrospinal fluid (CSF) in relation to systemic compartment in patients undergoing thoracic aortic surgery.
The aim of this study is to identify and unravel the biochemical (neuroinflammatory) pathways involved in postoperative delirium.
Patient undergoing thoracic aortic surgery will have an external lumbar drain (ELD) in situ on the day before surgery. This ELD remains in place during and three days after surgery to reduce the risk on periprocedural spinal cord ischemia. Paired measurements of CSF and blood will be analyzed.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Nijmegen, 6500HB, Netherlands
Location status: Recruiting
Major (cardiovascular) surgery is frequently associated with cerebral dysfunction postoperatively. Major surgical procedures account for substantial systemic inflammatory activation. Interestingly, animal models have shown that surgery rather than anaesthetics trigger a neurocognitive decline. An increase of pro-inflammatory cytokines and activation of immune cells mediate this post operative cognitive decline. There is growing support that systemic inflammation can activate the innate immune system of the brain leading to inflammation in the brain ('neuroinflammation'). This neuroinflammation is suggested to play a pivotal role in postoperative delirium and postoperative cognitive decline due to surgery-related systemic inflammation. However little evidence is available on the extend of the neuroinflammation and which biochemical pathways are dysregulated in the brain after surgery.
Thoracic aortic surgery offers the unique opportunity to study the trajectory of protein expression in CSF prior to and after surgery in a non-invasive matter. It is standard of care that an external lumbar drain (ELD) is placed the day prior to surgery and this ELD will remain in place during three postoperative days.
To advance the understanding of the impact of major surgery to the brain, the investigators wish to study the trajectory of protein expression prior to and after thoracic aortic surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Kinetics of neuroinflammatory markers in CSF and blood
Time frame: 9 timepoints: Baseline (immediately before surgery); Start extracorporeal circulation; Stop extracorporeal circulation (ECC); 2 hours (h) after stop ECC; 4h after stop ECC; 6h after stop ECC; 24h after baseline; 48h after baseline; 72h after baseline
Changes in CSF cytokine concentrations will be determined (including IL6, IL8, IL10, MCP-1, IL1RA and CX3CL1) between timepoints described below.
Time frame: 9 timepoints: Baseline to 72 hours after surgery
Changes in plasma cytokine concentrations will be determined (including IL6, IL8, IL10, MCP-1, IL1RA and CX3CL1) between timepoints described below.
Time frame: 9 timepoints: Baseline to 72 hours after surgery
CSF/Plasma albumine ratios will be measured for all timepoints where paired CSF/plasma samples are present
Time frame: 14-day incidence of delirium
Yes or No
Time frame: 9 timepoints: Baseline to 72 hours after surgery
Changes in brain injury markers will be determined (including NFL, S100B, GFAP, UCHL1, NSE)
Time frame: 9 timepoints: Baseline to 72 hours after surgery
Changes in brain injury markers will be determined (including S100B, GFAP, UCHL1, NSE)
Time frame: 5 timepoints: Baseline to 48 hours after surgery
TNF-a,IL6, IL10
Time frame: 5 timepoints: Baseline to 48 hours after surgery
monocytic HLA-DR expression assessed by flowcytometry
Contact information is provided by the study sponsor or research team.
Radboud University Medical Center
Other
Trajectory of Neuroinflammatory Markers in Cerebrospinal Fluid Prior to and After Thoracic Aortic Surgery: the TURBO Study
Acronym: TURBO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07719712
Cognition Disorders, Cognitive Dysfunction
Muğla, Turkey (Türkiye)
View Trial DetailsNCT05595954
Cardiovascular Diseases, Cognition Disorders
Basel, Switzerland
View Trial DetailsNCT05036538
Cognition Disorders, Cognitive Dysfunction
Bad Nauheim, Hesse, Germany
View Trial DetailsNCT04493996
Cognition Disorders, Cognitive Dysfunction
Bad Nauheim, Germany
View Trial Details